Error rendering component
Knudtzon disputerer for ph.d.-graden i helsevitenskap og vil offentlig forsvare avhandlingen:
Effects of age, sex and genetics on neurodegeneration and innate immune biomarkers in early Alzheimer´s disease
|
Avhandlingen er tilgjengelig her!
Prøveforelesningen vil også bli strømmet her/the trial lecture will also be streamed. Auditoriet er åpent for publikum, men disputasen vil likevel bli strømmet her. The auditorium is open to the public, but the defense will also be streamed here. |
![]() |
Populærvitenskapelig sammendrag av avhandlingen:
Alzheimer’s disease (AD) has a long preclinical phase, and AD-related biomarkers (amyloid beta (Aβ) and phosphorylated tau pathology) can be detected years before symptoms emerge. This thesis examined how age, sex, and genetics influence neurodegeneration, measured by total tau (t-tau) and neurofilament light chain (NfL), and innate immune activation in early AD. Participants were recruited from the national multicentre Dementia Disease Initiation study and underwent clinical examination, neuropsychological testing and cerebrospinal fluid (CSF) and blood sampling. Regression-based, age-adjusted norms for CSF t-tau and NfL were developed in Aβ-negative cognitively normal (CN) participants and tested in Aβ-positive participants with mild cognitive impairment (MCI). T-tau and NfL increased with age in CN, but age-adjustment reduced diagnostic accuracy and prediction of progression to MCI or dementia. This may suggest that age-related increases in t-tau and NfL reflect disease-related processes more than normal aging. Sex differences in innate immune markers were examined across Aβ-negative and Aβ-positive groups. Among Aβ-positive participants with MCI, females had lower MCP-1 and IL-6 than males. Females also showed stronger associations between neurodegeneration markers (t-tau and NfL) and the innate immune markers clusterin and sTREM2. This may indicate that sex-specific immune responses occur in Aβ-positive participants with MCI and may be relevant to sex differences in dementia development. Higher standard AD polygenic risk score (PRS) was associated with higher YKL-40 and sTREM2 with increasing NfL-related neurodegeneration. A higher AD-autoimmune-informed PRS (AD PRSINFL) was associated with lower sTREM2 at higher t-tau-related neurodegeneration. AD PRSINFL captured genotype-phenotype associations not detected by the standard AD PRS. These findings indicate that the two PRSs give different genetic predisposition to innate immune activation. This thesis shows that age, sex and genetics influence biomarker trajectories and innate immune phenotypes in early AD, with implications for earlier diagnosis and personalized follow-up.
Hovedveileder
Førsteamanuensis Bjørn-Eivind Kirsebom, IPS, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet.
Biveileder
Førsteamanuensis Kaja Nordengen, Oslo Universitetssykehus.
Bedømmelseskomité
Professor Michelle Marie Mielke, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. – 1. opponent.
Ph.d. Flora H. Duits, Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam University Medical Center, Location VUmc, Amsterdam, Nederland, - 2. opponent.
Professor Matthias Mittner, Institutt for psykologi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet – leder av komité.
Disputasleder:
Instituttleder per Håkan Brøndbo, Institutt for psykologi, Det helsevitenskapelige fakultet, UiT Norges arktiske universitet